34 results
PRE 14A
BDTX
Black Diamond Therapeutics Inc
12 Apr 24
Preliminary proxy
4:48pm
an understanding of the fiduciary responsibilities that are required of a member of the board of directors and the commitment of time and energy … acumen, integrity and an ability to exercise sound judgment, as well as a commitment of service to the Company and our board of directors.
The following
8-K
EX-10.2
BDTX
Black Diamond Therapeutics Inc
18 Sep 23
Black Diamond Therapeutics Announces CEO Transition
7:12am
not to bring any confidential information belonging to any other person or entity onto Company premises or into Company workspaces.
4. Commitment
8-K
EX-99.1
tgxbny4p
18 Sep 23
Black Diamond Therapeutics Announces CEO Transition
7:12am
8-K
EX-1.1
5tm2ewomx25tn3 wys
30 Jun 23
Entry into a Material Definitive Agreement
4:03pm
424B5
atmnor8
30 Jun 23
Prospectus supplement for primary offering
4:01pm
424B5
tasypnlq2lhds
29 Jun 23
Prospectus supplement for primary offering
6:02am
8-K
EX-99.1
tgbei32crs44s9pio
9 May 23
Black Diamond Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
7:43am
8-K
EX-99.1
r69zp
19 Dec 22
Black Diamond Therapeutics Announces Changes to Board of Directors
8:20am
S-3
iic 23zykdw9f3772xto
14 Nov 22
Shelf registration
4:15pm
DEF 14A
3s3bwya505hmtqkgyw
27 Apr 21
Definitive proxy
4:06pm
S-3ASR
EX-1.2
6lgr7k
1 Feb 21
Automatic shelf registration
5:28pm
S-3ASR
uolmj13mlu5v58xqz564
1 Feb 21
Automatic shelf registration
5:28pm
10-K
0ko2p8 nm8
24 Mar 20
Annual report
7:47am